TEVA logo

TEVA Cost of Revenue

Latest reported$1.99B
TEVA Quarterly Cost of Revenue ($0.00 → $1.99B)
High-resolution chart · PNG

TEVA cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Teva Pharmaceutical Industries Limited American Depositary Shares Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
1,989,000,000
2,011,000,000
2,056,000,000
2,176,000,000
2,074,000,000
2,014,000,000
2,109,000,000
2,183,000,000
2,140,000,000
2,048,000,000
2,041,000,000
1,999,000,000
2,082,000,000
2,079,000,000
2,113,000,000
1,926,000,000
1,992,000,000
1,921,000,000
2,050,000,000
2,093,000,000
2,037,000,000
2,104,000,000
2,405,000,000
2,126,000,000
2,107,000,000
2,294,000,000
2,510,000,000
2,435,000,000
2,443,000,000
2,440,000,000
2,588,000,000
2,508,000,000
2,640,000,000
2,717,000,000
2,917,000,000
2,967,000,000
2,865,000,000
2,811,000,000
3,102,000,000
2,762,000,000
2,161,000,000
2,019,000,000
2,034,000,000
2,052,000,000
2,064,000,000
2,146,000,000
2,279,000,000
2,249,000,000
2,384,000,000
2,304,000,000
2,536,000,000
2,429,000,000
2,331,000,000
2,311,000,000
2,464,000,000
2,371,000,000
2,337,000,000
2,493,000,000
2,795,000,000
2,098,000,000
2,012,000,000
1,892,000,000
1,954,000,000
1,783,000,000
1,679,000,000
1,640,000,000
1,703,000,000
1,622,000,000
1,631,000,000
1,576,000,000
1,249,000,000
1,350,000,000
1,318,000,000
1,200,000,000
1,229,000,000
1,116,000,000
1,143,000,000
1,043,000,000
1,174,800,000
1,024,000,000
1,001,100,000
949,100,000
724,500,000
698,700,000
645,400,000
701,200,000
706,800,000
657,700,000
623,100,000
572,000,000
509,000,000
435,400,000
404,100,000
409,000,000
431,000,000
360,700,000
324,900,000
306,600,000
327,177,000
300,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.